OBESITY TYPE 2 DIABETES MELLITUS
Clinical trials for OBESITY TYPE 2 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new OBESITY TYPE 2 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for OBESITY TYPE 2 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new stomach and gut bypass surgery tackle obesity and diabetes?
Disease control Not yet recruitingThis trial tests a new laparoscopic procedure called SIBS, which combines sleeve gastrectomy with a side-to-side connection between the duodenum and ileum, without cutting the duodenum. The goal is to see if the surgery is safe and technically feasible in adults with obesity and …
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Phase: NA • Sponsor: Medical City for Military and Security Services • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Poop pills vs. diabetes: can gut bacteria help shed pounds?
Disease control Not yet recruitingThis study tests whether adding fecal microbiota transplantation (FMT) to a calorie-restricted diet and a diabetes drug (semaglutide) helps people with obesity and type 2 diabetes lose more weight and improve metabolism. Twenty adults aged 18-60 with a BMI of 30-40 and diabetes f…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Phase: NA • Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New gut implant aims to tackle diabetes and obesity without surgery
Disease control Not yet recruitingThis study tests a temporary device placed in the upper small intestine to help control type 2 diabetes and obesity. The implant stays for 6 months and is then removed. Researchers will check if it lowers blood sugar (HbA1c), helps with weight loss, and improves liver health in p…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Phase: NA • Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
A blood marker may reveal how well diabetes treatments are working
Knowledge-focused Not yet recruitingThis study looks at whether levels of a protein called Neuregulin-4 (NRG4) in the blood are linked to obesity, insulin resistance, and different diabetes treatments in people with type 2 diabetes. Researchers will compare NRG4 levels across groups including obese and non-obese pa…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: GÜLDEN ANATACA • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Scientists investigate whether autoantibodies drive obesity
Knowledge-focused Not yet recruitingThis study looks at whether certain autoantibodies (proteins that mistakenly attack the body) are more common in people with obesity and if they are linked to related health problems like type 2 diabetes. Researchers will study 160 adults with a BMI over 30. The goal is to better…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: Claus Bogh Juhl • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
10,000 patients to reveal Real-World Weight-Loss success in china
Knowledge-focused Not yet recruitingThis registry study will follow 10,000 Chinese adults with obesity or overweight across 50 hospitals. Researchers will collect data on weight, lab tests, and liver health over 6 and 12 months. The goal is to understand current treatment patterns and outcomes in real-world clinica…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
10,000 volunteers needed to uncover hidden liver disease risks
Knowledge-focused Not yet recruitingThis study will screen up to 10,000 adults aged 18-75 who are overweight or have metabolic issues like high blood sugar or cholesterol. Researchers will use questionnaires, blood tests, and liver ultrasounds to find out how common fatty liver disease is and what factors increase …
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: Jarosław Drobnik • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC